Cargando…
Clinical Remission of Delta‐Aminolevulinic Acid Dehydratase Deficiency Through Suppression of Erythroid Heme Synthesis
Autores principales: | Neeleman, Rochus A., van Beers, Eduard J., Friesema, Edith C., Koole‐Lesuis, Rita, van der Pol, Willem L., Wilson, J.H. Paul, Langendonk, Janneke G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618255/ https://www.ncbi.nlm.nih.gov/pubmed/30724374 http://dx.doi.org/10.1002/hep.30543 |
Ejemplares similares
-
Medical and financial burden of acute intermittent porphyria
por: Neeleman, Rochus A., et al.
Publicado: (2018) -
Mortality in Pedigrees with Acute Intermittent Porphyria
por: Neeleman, Rochus, et al.
Publicado: (2022) -
Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers.
por: Alexander, B H, et al.
Publicado: (1998) -
Regulation of Delta-Aminolevulinic Acid Dehydratase by Krüppel-Like Factor 1
por: Desgardin, Aurelie D., et al.
Publicado: (2012) -
Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden.
por: Wetmur, J G
Publicado: (1994)